European Molecular Imaging Markets to Be Driven by Clinical Advances
|
By Nadia Liefsoens, MedImaging Regional Director Posted on 15 Jan 2013 |
|
The next big field of clinical application for molecular imaging, in addition to oncology and cardiology, will be neurology. This mounting user base is expected to increase revenues for the European molecular imaging market.
New market research from Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company, revealed that the markets earned revenues of USD 276.0 million in 2011 and estimates this to reach USD 388.4 million in 2018. The analysis encompasses single photon emission computed tomography (SPECT), positron emission tomography (PET), single and planar segments.
“The discovery of novel radiotracers is expanding the use of molecular imaging diagnostics to newer clinical applications,” noted Frost & Sullivan research analyst Kaavya Karunanithi. “In addition to the traditional fields of oncology and cardiology, neurology as well as infectious and inflammatory disease segments are increasingly leveraging molecular imaging techniques with radiotracers, thus widening the application base.”
Market penetration is also being driven by the prevalence and mindfulness of cancer. Procedural volumes of various cancer screening technologies, including PET and PET/CT, are rising. Additionally, the ability to simplify customized treatment is encouraging the use of molecular imaging technologies. Moreover, technologic developments continue to drive growth in the molecular imaging markets. For instance, hybrids such as the recently introduced PET/magnetic resonance imaging (MRI) provide higher specificities than currently available PET/computed tomography (CT).
“In the long run, optical modalities and tri-modality systems, with the ability to cater to a wider clinical application portfolio, will dominate,” added Ms. Kaavya. “Such technically advanced offerings boost market prospects, even while addressing the demand for personalized medicine.”
With these rapid technologic developments, there is a critical need for skilled technicians and physicians to effectively acquire and decipher images. This is an important challenge, which needs to be addressed. “Market participants must stay abreast of the high degree of technologic change,” advised Ms. Kaavya. “They will need to provide innovative, accurate, and reliable solutions that facilitate personalized medical care.”
Related Links:
Frost & Sullivan
New market research from Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company, revealed that the markets earned revenues of USD 276.0 million in 2011 and estimates this to reach USD 388.4 million in 2018. The analysis encompasses single photon emission computed tomography (SPECT), positron emission tomography (PET), single and planar segments.
“The discovery of novel radiotracers is expanding the use of molecular imaging diagnostics to newer clinical applications,” noted Frost & Sullivan research analyst Kaavya Karunanithi. “In addition to the traditional fields of oncology and cardiology, neurology as well as infectious and inflammatory disease segments are increasingly leveraging molecular imaging techniques with radiotracers, thus widening the application base.”
Market penetration is also being driven by the prevalence and mindfulness of cancer. Procedural volumes of various cancer screening technologies, including PET and PET/CT, are rising. Additionally, the ability to simplify customized treatment is encouraging the use of molecular imaging technologies. Moreover, technologic developments continue to drive growth in the molecular imaging markets. For instance, hybrids such as the recently introduced PET/magnetic resonance imaging (MRI) provide higher specificities than currently available PET/computed tomography (CT).
“In the long run, optical modalities and tri-modality systems, with the ability to cater to a wider clinical application portfolio, will dominate,” added Ms. Kaavya. “Such technically advanced offerings boost market prospects, even while addressing the demand for personalized medicine.”
With these rapid technologic developments, there is a critical need for skilled technicians and physicians to effectively acquire and decipher images. This is an important challenge, which needs to be addressed. “Market participants must stay abreast of the high degree of technologic change,” advised Ms. Kaavya. “They will need to provide innovative, accurate, and reliable solutions that facilitate personalized medical care.”
Related Links:
Frost & Sullivan
New
Biopsy Software
Affirm® Contrast
Multi-Use Ultrasound Table
Clinton
Wall Fixtures
MRI SERIES
Digital Radiographic System
OMNERA 300M
Latest Industry News News
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
Channels
Radiography
view channel
AI Improves Early Detection of Interval Breast Cancers
Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
MRI
view channel
Cutting-Edge MRI Technology to Revolutionize Diagnosis of Common Heart Problem
Aortic stenosis is a common and potentially life-threatening heart condition. It occurs when the aortic valve, which regulates blood flow from the heart to the rest of the body, becomes stiff and narrow.... Read more
New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes
Heart disease remains one of the leading causes of death worldwide. Individuals with conditions such as diabetes or obesity often experience accelerated aging of their hearts, sometimes by decades.... Read more
AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read moreUltrasound
view channel.jpeg "Image: The AI-powered lung ultrasound tool outperformed human experts by 9% in diagnosing TB (Photo courtesy of Adobe Stock)")
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Nuclear Medicine
view channel
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
General/Advanced Imaging
view channel
CT-Based Deep Learning-Driven Tool to Enhance Liver Cancer Diagnosis
Medical imaging, such as computed tomography (CT) scans, plays a crucial role in oncology, offering essential data for cancer detection, treatment planning, and monitoring of response to therapies.... Read more
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
